DR info

Clinical trials : 13 / Drugs : 19 - (DrugBank : 5) / Drug target genes : 18 - Drug target pathways : 10

Non-dystrophic myotonia syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
114	Non-dystrophic myotonia syndrome	-
13	Multiple sclerosis/Neuromyelitis optica	18.000
86	Pulmonary arterial hypertension	18.000
115	Hereditary periodic paralysis	13.000
154	Epilepsy with continuous spikes and waves during slow sleep	13.000
230	Alveolar hypoventilation syndrome	11.997
155	Acquired aphasia with convulsive disorder	11.008
225	Congenital nephrogenic diabetes insipidus	10.954
90	Retinitis pigmentosa	10.347
168	Ehlers-Danlos syndrome	3.395
140	Dorabe syndrome	3.346
144	Lennox-Gastaut syndrome	3.333
193	Prader-Willi syndrome	3.309
1	Spinal and bulbar muscular atrophy	3.194
156	Rett syndrome	3.111
10	Charcot-Marie-Tooth disease	3.030
97	Ulcerative colitis	2.932
6	Parkinson disease	2.882
38	Stevens-Johnson syndrome	2.593
256	Muscle glycogenosis	1.971
231	Alpha-1-antitrypsin deficiency	1.905
127	Frontotemporal lobar degeneration	1.840
58	Hypertrophic cardiomyopathy	1.765
36	Epidermolysis bullosa	1.757
107	Juvenile idiopathic arthritis	1.736
298	Hereditary pancreatitis	1.730
53	Sjogren syndrome	1.717
113	Muscular dystrophy	1.695
226	Interstitial cystitis with Hunners ulcer	1.671
28	Systemic amyloidosis	1.662
70	Spinal stenosis	1.662
84	Sarcoidosis	1.609
8	Huntington disease	1.604
34	Neurofibromatosis	1.596
51	Scleroderma	1.549
96	Crohn disease	1.496
2	Amyotrophic lateral sclerosis	1.494
46	Malignant rheumatoid arthritis	1.486